Abstract:Serous adenocarcinoma of the vaginal-urethral interspance with unknown origin has not previously been reported. Based on existing evidence, serous adenocarcinoma was considered to be a mesonephric adenocarcinoma. Mesonephric adenocarcinoma is a rare tumor of the female genital tract derived from mesonephric duct remnants or hyperplasia. Among the small number of reported cases, most are related to the uterus and cervix. There is no literature pertaining to optimal therapy, and little is known about the response to chemotherapeutic agents and prognosis. Here, we reported a case of a mesonephric adenocarcinoma of the vaginal-urethral interspace in a 43-year-old woman with 4 years of follow-up. A 43-year-old G2P1 was admitted to Peking University Third Hospital in October 2009 for evaluation of a 3-month history of frequent urination and an intermittent urinary stream. During the month prior to admission a urinary catheter had to be placed twice due to retention of urine. The patient had a cesarean section 21 years earlier and an intrauterine device in situ for 20 years with regular menstruation. A pelvic examination revealed a normal uterus and cervix, but a 5 cm well-circumscribed submucous mass was identified in the middle segment of the anterior vaginal wall. The CA-125, 19-9, AFP, CEA, and SCC were all negative. A cystoscopy was negative and a transvaginal ultrasound described a cystic and solid mass in the anterior vaginal wall with abundant flow signals involving the solid portion. A pelvic CT scan showed a 6.3 cm ×6.6 cm mass in the urethral canal extending toward the anterior vaginal wall and anterior lower uterine segment, suggestive of a myoma (Figure 1A).Figure 1. A: : CT scan of the pelvis. B, C: Findings in the operation. D: Pathologic findings (HE, original magnification ×200).Resection of the mass was performed and confirmed to be a 5cm cystic and solid mass in the middle segment of the vaginal-urethral interspace with a clear boundary. The mass was filled with yellow and white soft tissue and had a hard capsule (Figure 1B, C). Frozen pathology revealed a moderate-to-low differentiated adenocarcinoma. Removal of the intrauterine device (IUD) and fractional curettage were performed and frozen pathology revealed no carcinoma. All of the symptoms were relieved after surgery. The pathologic evaluation showed a glandular papillary structure with focal solid and cellular atypia that was consistent with a low differentiated carcinoma (Figure 1D). The tissue was positive for p53, chemokine (CK) 7, and vimentin, and negative for estrogen receptor (ER), progesterone receptor (PR), CK 20, and carcinoembryonic antigen (mCEA). Histologic sections of the endometrium showed proliferative endometrium without carcinoma and chronic inflammatory columnar epithelium mucosa within the cervical canal. One month after the primary surgery she underwent laparoscopic and hysteroscopic explorations. Bilateral fallopian tube biopsies of the fimbria, ovaries and omentum were obtained. All sections were free of tumor. Enteroscopy and gastroscopy were negative. Three months later a hysteroscopic exploration was performed to evaluate an unusual echo in the cervical canal noted during ultrasonography. A polyp-like tissue was removed from the cervix; no suspicious masses were visualized. Post-operatively, she received chemotherapy in another hospital for only two cycles due to intolerance. The post-operative diagnosis was mesonephric adenocarcinoma of the vaginal-urethral interface. At the time of the most recent follow-up, four years after surgery, she came back in December 2013 for total hysterectomy and bilateral salpingo-oophorectomy because of hydrosalpinx and anxiety of recurrence. There was no difficulty with urination, the vaginal mucosa was well healed, and there was no evidence of recurrence or metastasis. Mesonephric tumors are rare. They are found around mesonephric remnant sites, such as the broad ligaments, fallopian tubes, and ovarian hila, which are pathologically like mesonephric ducts. Cases of mesonephric tumors have been reported in the vagina, uterine corpus, cervix, broad ligament, urinary bladder, urethra, and urethral diverticulum. In most cases, the patients were asymptomatic, masses were solitary and not invasive or metastatic.1-3 Therefore, we only removed the mass in our case. Based on pathologic evaluation, cells of the mesonephric remnants are cube-shaped without cilia and have no mucous production, which differs from paramesonephric ducts, and from the thick eosinophilic secretions in the lumen. Immunohistochemical studies of cervical mesonephric adenocarcinoma specimens have shown that epithelial markers, including pancytokeratin, CAM5.2, CK7, and EMA, are consistently present in the tumor cells, which are negative for CK20, CEA, ER, and PR. Using antibodies, two large series of 49 and 14 cases reported no sequelae of mesonephric remnants or hyperplasia.4 In a vaginal case of mesonephric hyperplasia, radiotherapy and chemotherapy brachytherapy was used secondary to the close vaginal margin.1 In our case, the tissue was positive for p53 and negative for ER and PR, consistent with a serous carcinoma. A problem of the tumor origin arose as there was no epidermis in the vaginal-urethral interspace. There might be three possible origins of the tumor: primary, urinary or digestive system. Clear mucosa of the vagina, negative hysteroscopic and laparoscopic result might rule out the possibility of a primary serous carcinoma. Tumors of urinary system were generally positive for both CK7 and 20, while in our case urinary system was not involved and the tumor was only positive for CK 7. Absence of digestive tract symptoms and negative gastroscopy and enteroscopy ruled out a digestive system origin. The most uncommon finding was that, unlike a common serous carcinoma of the genital system, there was no evidence of recurrence and metastasis after four years of follow-up. Because of the above reasons, we consider the tumor to be related to mesonephric remnants and diagnosed it to be a mesonephric adenocarcinoma of the vaginal-urethral interspace.

Encapsulated papillary carcinoma originating from the vulva anogenital mammary-like glands: a rare case report

Adenocarcinoma of anogenital mammary gland type arising from encapsulated papillary carcinoma: A rare vulvar tumor mimicking breast carcinoma

Management of Primary Female Urethral Adenocarcinoma: Two Rare Case Reports and Literature Review

Case report: Primary vulvar adenocarcinoma of mammary gland type—its genetic characteristics by focused next-generation sequencing

Fibroadenoma of the vulva with pseudoangiomatous stromal hyperplasia: A common neoplasm in uncommon site

Primary Mucinous Adenocarcinoma of the Vulva: A Case Report and Review of the Literature.

Human Papillomavirus–Associated Multiphenotypic Carcinoma: First Description of a Vulval Case

Primary Adenoid Cystic Carcinoma of Sweat Glands in Vulva: Report of an Unusual Case and Review of the Literature

Vulvar Lactating Adenoma: A Rare Representation of Mammary-Like Anogenital Glands

Prepubertal vulval fibroma with a coincidental ectopic breast fibroadenoma: report of an unusual case with literature review.

Prepubertal Vulval Fibroma with a Coincidental Ectopic Breast Fibroadenoma: Report of an Unusual Case with Literature Review

Adenosquamous carcinoma of the vulva: Rare tumor with unusual clinical presentation

High-grade Neuroendocrine Carcinomas of the Vulva: A Clinicopathologic Study of 16 Cases

Cystic encapsulated papillary carcinoma with ductal carcinoma in situ in the male breast: a clinicopathologic feature with a diagnostic challenge: A case report and review of literature

Individualized vaginal applicator for stage IIb primary vaginal adenocarcinoma: A case report

Contrast-enhanced Ultrasound Combined with Ultrasonic Elastography to Diagnose Encapsulated Papillary Carcinoma: A Case Report

Thin-Layer Cytology Findings of Papillary Adenosquamous Carcinoma of the Cervix

Mesonephric Adenocarcinoma of the Vaginal-Urethral Interspace

TP53 Mutation-driven Stratified Mucin-producing Carcinoma Coexisting With Squamous Cell Carcinoma of the Vulva: A Case Study

Vulvar Hidradenoma Papilliferum

A rare case of concomitant endometrioid adenocarcinoma arising from uterine adenomyosis and clear cell carcinoma arising from parametrial deep endometriosis